Australia Personalized Medicine Market Size & Outlook

The personalized medicine market in Australia is expected to reach a projected revenue of US$ 18,842.8 million by 2030. A compound annual growth rate of 11.2% is expected of Australia personalized medicine market from 2024 to 2030.
Revenue, 2023 (US$M)
$8,952.5
Forecast, 2030 (US$M)
$18,842.8
CAGR, 2024 - 2030
11.2%
Report Coverage
Australia

Australia personalized medicine market, 2018-2030 (US$M)

Australia

Australia personalized medicine market highlights

  • The Australia personalized medicine market generated a revenue of USD 8,952.5 million in 2023 and is expected to reach USD 18,842.8 million by 2030.
  • The Australia market is expected to grow at a CAGR of 11.2% from 2024 to 2030.
  • In terms of segment, personalized nutrition & wellness was the largest revenue generating product in 2023.
  • PM Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.


Personalized medicine market data book summary

Market revenue in 2023USD 8,952.5 million
Market revenue in 2030USD 18,842.8 million
Growth rate11.2% (CAGR from 2023 to 2030)
Largest segmentPersonalized nutrition & wellness
Fastest growing segmentPM Therapeutics
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness
Key market players worldwideGE HealthCare Technologies Inc Common Stock, Illumina Inc, Asure Software Inc, Abbott Laboratories, Danaos Corp, Exact Sciences Corp, Danaher Corp, Amgen Inc, Qiagen NV, Exagen Inc Ordinary Shares, Quest Diagnostics Inc, Biogen Inc, Genelux Corp, International Business Machines Corp, Genentech, 23andMe Holding Co Class A


Other key industry trends

  • In terms of revenue, Australia accounted for 1.7% of the global personalized medicine market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China personalized medicine market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 52,685.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Personalized Medicine Market Companies

Name Profile # Employees HQ Website

Australia personalized medicine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized medicine market will help companies and investors design strategic landscapes.


Personalized nutrition & wellness was the largest segment with a revenue share of 33.38% in 2023. Horizon Databook has segmented the Australia personalized medicine market based on pm diagnostics, pm therapeutics, personalized medical care, personalized nutrition & wellness covering the revenue growth of each sub-segment from 2018 to 2030.


Australia’s personalized medicine market is expected to grow significantly due to research collaborations, favorable government initiatives, increased prevalence of target diseases, and advanced healthcare infrastructure.

In January 2022, the Australian government announced an investment of USD 10 million in medical research to identify innovative methods to enhance participation in the country's programs for screening bowel, breast, & cervical cancers. Such developments are expected to boost the personalized medicine market in Australia during the forecast period.

In July 2023, the Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT), an Australian cancer genomics initiative, was launched. The initiative was launched with the partnership of Omico and UNSW's new Centre for Molecular Oncology (CMO).

Reasons to subscribe to Australia personalized medicine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia personalized medicine market databook

  • Our clientele includes a mix of personalized medicine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia personalized medicine market , including forecasts for subscribers. This country databook contains high-level insights into Australia personalized medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia personalized medicine market size, by product, 2018-2030 (US$M)

Australia Personalized Medicine Market Outlook Share, 2023 & 2030 (US$M)

Australia personalized medicine market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more